CONDITION

Hepatic Lipidosis

Hepatic lipidosis describes a state in which fat accumulates inside liver cells to the point where the liver struggles to function normally. It develops most commonly in cats, typically after a period of not eating, sometimes only a few days, and often follows a stressful event, illness, or abrupt change in routine. The underlying trigger may be obvious or subtle. Owners often notice their cat has stopped eating, appears lethargic, and may begin to show a yellow tinge to the skin, gums, or whites of the eyes. Weight loss tends to be noticeable, though the cat may have been overweight beforehand. Vomiting or excessive drooling can occur, and some cats seem uncomfortable or reluctant to move. This page explores the signals that can appear, what is happening inside the liver and why fat builds up in this way, how the condition is investigated through blood tests and imaging, and the range of approaches used to support recovery. The focus throughout is on helping you understand the shape of the condition and the decisions that may follow.

Why this matters now

Among pets, hepatic lipidosis is seen mainly in cats (rabbits, guinea pigs and ferrets can also develop it), and it can develop at any age, though middle-aged and overweight cats appear more susceptible. The pattern often begins after anything from a few days to several weeks of eating little or nothing, which may follow a stressful event, a change in household routine, the introduction of a new diet, or an underlying illness that suppresses appetite. An underlying illness such as pancreatitis, inflammatory liver or bowel disease, diabetes or cancer is found in most cats. The proportion with no identifiable trigger varies between studies, from under one in ten to more than a quarter. In a multi-cat household, or where food is left out all day, a fall in one cat's intake can go unnoticed for several days.

Hepatic lipidosis can develop after as little as two to three days without food, and in reported cases the period of poor eating beforehand ranges from a few days to several weeks, so partial eating carries risk as well as complete refusal. By the time a yellow tinge is visible in the eyes or gums, bilirubin is already well above normal. Without nutritional support, mortality in severely affected cats is reported to exceed 90 per cent; with early feeding-tube support, published survival figures are roughly 60 to 80 per cent or higher. Dullness, weakness, heavy drooling and failing liver function at diagnosis are associated with poorer survival. Low potassium (about three in ten cats at diagnosis) and clotting abnormalities are common in affected cats and cannot be detected at home. Low phosphate is less common at first, but potassium and phosphate can both fall sharply once feeding restarts.

Signals & patterns

Early signals

Reduced interest in food

The cat may approach the bowl but eat only small amounts, or turn away from food that was previously appealing. This change can be gradual or quite sudden, and may initially be mistaken for fussiness or a preference shift. Eating noticeably less than usual over a few days carries risk, not only complete refusal.

Quieter than usual

Many cats become less active and spend more time resting in secluded spots. The change in energy level may be subtle at first, noticed more in hindsight once other signs appear.

Weight loss

Loss of body condition may become visible over days to weeks, particularly in cats who were overweight to begin with. The abdomen may look smaller, and muscle over the spine and hips may feel less prominent.

Occasional vomiting

Some cats vomit small amounts of fluid or bile, often in the morning or after attempting to eat. The vomiting may be intermittent and can contribute further to the reluctance to eat.

Later signals

Yellow tinge to skin or eyes

A yellowish colour may become visible in the whites of the eyes, inside the ears, or on the gums. This change, known as jaundice, reflects a build-up of bilirubin as liver function declines. It usually becomes visible only once bilirubin is well above normal, so its absence in the early days is not reassurance.

Marked lethargy or weakness

The cat may become reluctant to move, show little interest in surroundings, or lie in unusual postures. Interaction with people or other animals often decreases noticeably. Some cats hold the head bent down towards the chest, a sign linked to severe low potassium, low phosphate or thiamine deficiency.

Drooling or lip-smacking

Some cats drool heavily or make repeated lip-smacking movements. This can reflect nausea or, in more advanced cases, effects on the brain from liver failure or from disturbed body chemistry, and heavy drooling at diagnosis is linked to poorer survival. This sign can be distressing for owners to observe.

Changes in behaviour or mental state

In more advanced cases, cats may appear disorientated, less responsive, or show altered sleep-wake patterns. These signs can reflect the accumulation of metabolic by-products that affect brain function.

Click to read about the biological mechanisms

How this is usually investigated

Investigation typically begins with a detailed history, particularly the duration and circumstances surrounding any period of reduced eating, and any concurrent stressors or illness. Physical examination may reveal jaundice, weight loss, an enlarged liver, and sometimes muscle wasting. Blood tests and imaging are then used to assess liver function, rule out other causes of liver disease, and evaluate the degree of fat accumulation.

Physical examination

Purpose: Allows assessment of body condition, hydration status, presence of jaundice in the gums and whites of the eyes, liver size by feeling the abdomen, and general demeanour.

Considerations: Jaundice may not be apparent in early cases, and liver enlargement can be difficult to appreciate in overweight cats or those with tense abdominal muscles. The examination provides context but cannot confirm the diagnosis.

Chemistry panel

Purpose: Measures liver enzymes, bilirubin, albumin, glucose, and other markers of organ function. In hepatic lipidosis, ALP (alkaline phosphatase) is typically markedly elevated while GGT (gamma-glutamyl transferase) remains normal or only mildly raised, a pattern that helps distinguish this condition from other feline liver diseases such as cholangitis.

Considerations: The degree of enzyme elevation does not always correlate with prognosis. A raised bilirubin level develops as liver function declines but may be mild early on, and other conditions can produce overlapping biochemical changes.

Complete blood count

Purpose: Identifies anaemia, which can develop in cats with prolonged illness, and may reveal changes in white cell populations that point towards concurrent infection or inflammation.

Considerations: Abnormalities, when present, tend to be non-specific and may reflect secondary processes rather than the liver condition itself.

Abdominal ultrasound

Purpose: Reveals the characteristic hyperechoic (bright) appearance of a fatty liver and allows assessment of liver size, bile duct architecture, and the presence of masses or signs of other hepatobiliary disease.

Considerations: A hyperechoic liver is suggestive but not specific to hepatic lipidosis, and imaging alone cannot confirm the diagnosis. Ultrasound may also identify concurrent conditions that contributed to the initial loss of appetite.

Cytology

Purpose: Fine-needle aspirates of the liver examined under the microscope can reveal fat vacuoles within liver cells, confirming the presence of lipid accumulation and supporting the diagnosis when combined with clinical and biochemical findings.

Considerations: Cytology is less invasive than biopsy and often sufficient for diagnosis, though it samples only a small area and may miss focal lesions. The procedure carries a small risk of bleeding, particularly in cats with clotting abnormalities.

Clotting times and electrolytes

Purpose: Measures how well the blood clots and the levels of potassium, phosphate and magnesium. Low potassium is present in a proportion of cats at diagnosis, and persistent low potassium is linked to poorer survival.

Considerations: Clotting abnormalities are common in cats with liver disease, often from reduced vitamin K activity, and are usually addressed before liver sampling or tube placement. Electrolyte levels can shift once feeding restarts, so they are often rechecked during the first days of treatment.

Options & trade-offs

Management centres on reversing the fat accumulation by restoring adequate caloric and protein intake, addressing any underlying condition that triggered the loss of appetite, and supporting liver function during recovery. The combination of approaches varies depending on the severity of illness, the cat's tolerance of different feeding methods, and the practicalities of home care. Different cats and households find different strategies workable.

Nutritional support via feeding tube

A tube placed into the oesophagus or stomach allows delivery of liquid nutrition in measured amounts throughout the day, bypassing the need for voluntary eating while the liver recovers. Tubes can remain in place for weeks and are typically managed at home once the technique is learned. Nutritional plans are tailored to provide sufficient calories and protein.

Trade-offs: Oesophagostomy and gastrostomy tubes require anaesthesia, which carries risk in unwell cats, and placing them carries a bleeding risk in cats with clotting problems. A thinner tube passed through the nose can often be placed without sedation and used in the first days while the cat is stabilised. Some owners find the prospect of managing a feeding tube at home daunting. The approach allows precise control of intake but does not address the cat's underlying reluctance to eat, and weaning back to voluntary feeding can take time. Feeding is typically built up over several days while potassium and phosphate are monitored, because restarting nutrition after a period of starvation can cause these to fall sharply, a complication known as refeeding syndrome.

Appetite stimulants and assisted feeding

Medications that stimulate appetite, such as mirtazapine (authorised for cats as an ointment absorbed through the skin, with human tablets used under the veterinary cascade) or capromorelin (authorised for cats as an oral liquid), may encourage voluntary eating in cats with milder cases or during recovery. Both are authorised for weight gain in cats whose poor appetite is linked to longer-term illness, and the product information for each carries a caution for cats with liver disease. Syringe feeding or hand feeding small amounts of palatable food can supplement intake when a cat is willing to accept it but not eating independently.

Trade-offs: Appetite stimulants are less reliable in severely affected cats and cannot guarantee adequate caloric intake. Syringe or forced feeding can be stressful for both cat and owner, carries a risk of food being inhaled into the airway, and can create a lasting aversion to food; if intake remains insufficient, the liver continues to accumulate fat rather than mobilising it.

Intravenous fluid therapy and electrolyte correction

Cats with hepatic lipidosis are often dehydrated and may have disturbances in potassium, phosphate, or other electrolytes. Intravenous fluids restore hydration and allow correction of imbalances, supporting overall metabolic stability during the early phase of treatment.

Trade-offs: Fluid therapy requires hospitalisation or repeated visits and does not address the core problem of caloric deficit. It is a supportive measure rather than a standalone treatment, and over-aggressive fluid administration can worsen complications in some cases.

Treatment of underlying or concurrent conditions

Identifying and managing the illness or stressor that initially caused the cat to stop eating is an important part of recovery. This may involve antibiotics for infection, pain relief, anti-nausea medication, or addressing environmental stressors. The liver can begin to recover once the trigger is removed and nutrition is restored.

Trade-offs: The underlying cause is not always apparent, and in some cases multiple factors may have contributed. Diagnostic investigation adds cost and time, and treatment of concurrent disease does not alone reverse hepatic lipidosis without nutritional intervention.

Gradual reintroduction of normal diet

As liver function improves and the cat begins to show interest in food, the transition from tube feeding or liquid nutrition to a normal diet occurs in stages. Palatable, energy-dense foods are offered in small amounts, and intake is monitored to ensure the cat continues to meet its caloric needs.

Trade-offs: Some cats remain reluctant to eat voluntarily even after clinical improvement, and premature removal of feeding support can lead to relapse. The weaning process may take weeks, and appetite can fluctuate unpredictably during recovery.

Common misconceptions

Misconception:

"Hepatic lipidosis only affects obese cats."

Reality:

Overweight and obese cats are at higher risk, but any cat that stops eating for a sufficient period can develop hepatic lipidosis. Lean cats can be affected, particularly if they go without food for longer because of illness or stress. Body condition influences susceptibility but does not determine whether the condition will occur.

Misconception:

"Once a cat starts eating again, the liver will recover on its own without further intervention."

Reality:

Eating again is only the start: recovery depends on sustained, adequate caloric and protein intake over weeks to months, along with management of any underlying illness. Intermittent or insufficient eating does not reverse the fat accumulation and may allow the condition to worsen. Structured nutritional support is typically required.

Misconception:

"Hepatic lipidosis is a primary liver disease caused by a defect in the liver itself."

Reality:

Hepatic lipidosis is a metabolic response to a period of not eating enough, most often triggered by another illness, rather than an inherent defect of the liver. In many cats the liver was healthy beforehand, although lipidosis can also develop alongside existing liver disease such as cholangitis. Fat accumulation occurs because the body mobilises fat faster than the liver can process it, and the change can reverse when nutrition is restored and the trigger is addressed.

Related conditions

Acute Pancreatitis

Acute pancreatitis can occur alongside hepatic lipidosis in cats, and the two conditions may share overlapping signs such as vomiting, loss of appetite, and lethargy. In some cases, inflammation in the pancreas and fat accumulation in the liver develop concurrently, particularly when a period of poor eating has preceded both.